Inhibrx Biosciences, Inc.

Biotechnology • Healthcare • La Jolla, CA, United States • INBX (NMS)

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Inhibrx Biosciences’ stock soars on chondrosarcoma Phase II victory - Clinical Trials Arena

Clinical Trials Arena • Oct 24

Inhibrx Reports Third Quarter 2025 Financial Results - PR Newswire

PR Newswire • Nov 14

Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX), - Yahoo Finance

Yahoo Finance • Oct 11

Why Is Inhibrx Stock Rising? - StocksToTrade

StocksToTrade • Oct 24

Citizens reiterates Market Perform rating on Inhibrx Biosciences stock citing limited data disclosures - Investing.com

Investing.com • Dec 17

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Inhibrx Biosciences, Inc. had layoffs?

No layoff events have been recorded for Inhibrx Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Inhibrx Biosciences, Inc. have?

Inhibrx Biosciences, Inc. has approximately 156 employees.

What industry is Inhibrx Biosciences, Inc. in?

Inhibrx Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Inhibrx Biosciences, Inc. a publicly traded company?

Yes, Inhibrx Biosciences, Inc. is publicly traded under the ticker symbol INBX on the NMS. The company has a market capitalization of approximately $1.15 billion.

Where is Inhibrx Biosciences, Inc. headquartered?

Inhibrx Biosciences, Inc. is headquartered in La Jolla, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.